Analysis Article • May 20
Have your own idea? Try our Stock Screener
Canadian (TSX) Biotech Industry Analysis
UpdatedMay 23, 2026
DataAggregated Company Financials
Companies24
- 7D6.7%
- 3M-10.3%
- 1Y19.8%
- YTD-3.3%
In the last week, the Biotech industry is up 3.1%, with Bright Minds Biosciences up 13%. In the same time, ME Therapeutics Holdings was down 32%. This means that the industry has gained 16% over the past year. As for the next few years, earnings are forecast to decline by 12% per annum.
Industry Valuation and Performance
Has the Canadian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 23 May 2026 | CA$2.8b | CA$90.9m | -CA$259,387,347.52 | 17.8x | -10.9x | 31.2x |
| Mon, 20 Apr 2026 | CA$2.8b | CA$85.7m | -CA$243,437,189.77 | 54x | -11.4x | 32.3x |
| Wed, 18 Mar 2026 | CA$2.6b | CA$92.5m | -CA$253,444,900.23 | 50.6x | -10.2x | 27.9x |
| Fri, 13 Feb 2026 | CA$2.7b | CA$95.5m | -CA$241,233,629.59 | 21.6x | -11.1x | 28.1x |
| Sun, 11 Jan 2026 | CA$2.5b | CA$95.8m | -CA$244,384,726.41 | 23.8x | -10.3x | 26.3x |
| Tue, 09 Dec 2025 | CA$2.4b | CA$98.0m | -CA$235,920,313.78 | 23.1x | -10.1x | 24.3x |
| Thu, 06 Nov 2025 | CA$2.1b | CA$95.8m | -CA$232,931,058.43 | 24.3x | -9.1x | 22.1x |
| Sat, 04 Oct 2025 | CA$2.1b | CA$95.7m | -CA$225,894,468.83 | 25x | -9.3x | 21.9x |
| Mon, 01 Sep 2025 | CA$1.6b | CA$95.4m | -CA$220,566,337.64 | 28.5x | -7.5x | 17.2x |
| Wed, 30 Jul 2025 | CA$1.6b | CA$91.1m | -CA$206,625,279.35 | 22.6x | -7.7x | 17.4x |
| Fri, 27 Jun 2025 | CA$1.5b | CA$90.6m | -CA$285,651,532.34 | 22.4x | -5.1x | 16.1x |
| Sun, 25 May 2025 | CA$1.5b | CA$91.5m | -CA$303,160,201.57 | 23.1x | -5.1x | 16.7x |
| Tue, 22 Apr 2025 | CA$1.4b | CA$92.0m | -CA$285,600,905.53 | 19.2x | -4.8x | 15x |
| Thu, 20 Mar 2025 | CA$1.5b | CA$88.6m | -CA$310,881,381.05 | 21.8x | -4.9x | 17x |
| Sat, 15 Feb 2025 | CA$1.7b | CA$85.1m | -CA$318,006,401.35 | 34.8x | -5.4x | 20x |
| Mon, 13 Jan 2025 | CA$1.5b | CA$87.5m | -CA$319,430,859.65 | 24.5x | -4.5x | 16.6x |
| Wed, 11 Dec 2024 | CA$1.5b | CA$83.4m | -CA$311,377,405.28 | 9.5x | -4.8x | 17.9x |
| Fri, 08 Nov 2024 | CA$1.5b | CA$80.4m | -CA$281,733,772.85 | 8.6x | -5.3x | 18.7x |
| Sun, 06 Oct 2024 | CA$1.1b | CA$80.2m | -CA$278,014,036.71 | 9.4x | -3.8x | 13.3x |
| Tue, 03 Sep 2024 | CA$996.5m | CA$80.2m | -CA$281,245,145.39 | 10.2x | -3.5x | 12.4x |
| Thu, 01 Aug 2024 | CA$1.1b | CA$76.2m | -CA$332,870,822.92 | 11.4x | -3.4x | 14.9x |
| Sat, 29 Jun 2024 | CA$1.1b | CA$76.8m | -CA$349,897,724.17 | 10.1x | -3.1x | 14.1x |
| Mon, 27 May 2024 | CA$1.1b | CA$77.1m | -CA$368,268,249.48 | 10.8x | -3.1x | 14.6x |
| Wed, 24 Apr 2024 | CA$866.1m | CA$79.5m | -CA$300,992,465.24 | 12.4x | -2.9x | 10.9x |
| Fri, 22 Mar 2024 | CA$1.1b | CA$91.6m | -CA$321,114,526.39 | 11.1x | -3.4x | 11.9x |
| Sun, 18 Feb 2024 | CA$1.2b | CA$93.1m | -CA$323,296,548.68 | 12.6x | -3.6x | 12.5x |
| Tue, 16 Jan 2024 | CA$3.6b | CA$86.3m | -CA$516,496,022.00 | 6.8x | -6.9x | 41.4x |
| Thu, 14 Dec 2023 | CA$3.7b | CA$86.0m | -CA$542,317,363.00 | 5.9x | -6.8x | 43.1x |
| Sat, 11 Nov 2023 | CA$3.8b | CA$86.1m | -CA$544,553,712.00 | 6.3x | -7x | 44.3x |
| Mon, 09 Oct 2023 | CA$3.8b | CA$89.0m | -CA$525,742,736.00 | 6.2x | -7.3x | 43.1x |
| Wed, 06 Sep 2023 | CA$4.0b | CA$87.4m | -CA$507,182,276.00 | 6.2x | -8x | 46.1x |
| Fri, 04 Aug 2023 | CA$4.0b | CA$82.0m | -CA$516,439,737.00 | 6.8x | -7.7x | 48.5x |
| Sun, 02 Jul 2023 | CA$4.1b | CA$81.6m | -CA$516,919,547.00 | 13.4x | -7.8x | 49.7x |
| Tue, 30 May 2023 | CA$3.8b | CA$86.6m | -CA$607,590,948.00 | 13.5x | -6.3x | 43.9x |
Price to Earnings Ratio
-6.3x
Current Industry PE
- Investors are optimistic on the Canadian Biotechs industry, and appear confident in long term growth rates.
- The industry's 3-year average PS ratio of 24.8x is exceeded by the industry's current PS ratio of 30.9x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 1.53% | |
| Healthcare | 1.29% | |
| Biotech | 6.74% | |
| Biotech | 6.74% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | CA$116.19 | 13.5% +CA$138.0m | 192.1% | PB3.7x | |
| PAIN Vector Science and Therapeutics | CA$1.26 | 37.0% +CA$52.1m | n/a | PB81x | |
| ATLE Atlas Energy | CA$0.19 | 11.8% +CA$12.6m | 8.6% | PB4.6x | |
| EPRX Eupraxia Pharmaceuticals | CA$9.70 | 1.7% +CA$10.5m | 84.4% | PB4.2x | |
| EDT Spectral Medical | CA$1.42 | 1.4% +CA$5.9m | 71.1% | PS150.9x |